SEVERE HYPERTRIGLYCERIDEMIA
Clinical trials for SEVERE HYPERTRIGLYCERIDEMIA explained in plain language.
Never miss a new study
Get alerted when new SEVERE HYPERTRIGLYCERIDEMIA trials appear
Sign up with your email to follow new studies for SEVERE HYPERTRIGLYCERIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to tame dangerous fat levels in blood
Disease control CompletedThis study tested a drug called pegozafermin in 369 adults with severe hypertriglyceridemia, a condition where blood fat levels are dangerously high. Participants received either the drug or a placebo for 26 weeks. The main goal was to see if the drug could safely lower triglycer…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: 89bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New shot shows promise for stubborn high fats in blood
Disease control CompletedThis study tested a drug called olezarsen in 154 adults with high triglycerides (a type of blood fat) and either heart disease or very high triglycerides. Participants received injections of the drug or a placebo for up to 12 months. The main goal was to see if the drug could low…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE2 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New shot cuts dangerous fat levels in half
Disease control CompletedThis study tested an experimental drug called ARO-APOC3 in 229 adults with severely high triglycerides (a type of blood fat). Participants received two injections of the drug or a placebo. The goal was to see if the drug could safely lower triglyceride levels. Results showed sign…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New shot could tame dangerous blood fats
Disease control CompletedThis Phase 3 trial tested a drug called olezarsen in 617 people with severe hypertriglyceridemia (very high blood fats). Participants received either the drug or a placebo as a shot under the skin. The main goal was to see if olezarsen could lower triglyceride levels more than pl…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New injection shows promise for dangerous fat levels
Disease control CompletedThis study tested a new drug called DR10624 in 79 adults with severely high triglycerides, a type of blood fat that raises the risk of heart problems. Participants received injections under the skin for 12 weeks. The main goal was to see if the drug safely lowers triglyceride lev…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE2 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New shot cuts dangerous fat levels in blood
Disease control CompletedThis study tested a new medicine called olezarsen in 446 people with very high levels of blood fats (triglycerides). The goal was to see if it could lower these fats more than a placebo. Participants received shots under the skin and followed a healthy diet.
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC